| Last price paid | n.a. | |
| Change | -33.33% [ -0.01 ] | |
| Last traded volume | n.a. Unit | |
| Cumulative volume | n.a. Unit | |
| Date/time | n.a. n.a. | |
| Initial fixing date | 21.11.2025 |
| Settlement date | 01.12.2025 |
| Last trading | 16.01.2026 |
| Final fixing | 16.01.2026 |
| Currency redemption | CHF |
| Perf. since issue | -97.56% |
| Year to date (YTD) | -88.24% |
| 1 month | -91.67% |
| 3 months | n.a. |
| 1 year | n.a. |
| 3 years | n.a. |
| Issue price | 0.43 |
| Underlying price on issue | 1'038.04 |
| Premium | 0.07% |
| Premium p.a. | 2.41% |
| Leverage | 57.08 |
| Implied volatility | 0.25 |
| ISIN | CH1507454242 |
| Symbol | LLY8IZ |
| Security | 150745424 |
| Exchange | SIX Structured Products |
| Currency | CHF |
| Expiry | 26.01.2026 |
| Underlying | Eli Lilly & Co Rg, US5324571083 |
| Underlying ISIN | US5324571083 |
| Strike | 1'100.00 |
| C/P type | call |
| Subscription ratio | 100.00 |
| Issuer | Zuercher Kantonalbank |
| Exercise type | American |
| Delivery of securities | Automatic |
| Minimum execution | 100 |
| Value day | 21.11.2025 |
| Premium | 6.62% |
| Premium p.a. | 241.48% |
| Leverage | 788.72 |
| Implied volatility | 24.94% |
| Moneyness | out-of-the-money |
| Leverage | 57.0787 |
| Delta | 0.0724 |
| Gamma | 0.0000 |
| Theta | -0.0023 |
| Rho | 0.0002 |
| Vega | 0.0018 |
| Fair value | 0.01 |
| Intrinsic value | n.a. |
| Break-even | 1'101.31 |
| SSPA value at risk | n.a. |
| SSPA risk rating | n.a. |
| SSPA derivative category | Leverage |
| SSPA code | Warrant (2100) |
| Name | Price |
|---|---|
| KUEHNE & NAGEL | 187.25 |
| SWISSCOM N | 671.50 |
| ZURICH INSURANCE | 570.80 |
| Alcon AG | 60.32 |
| Swiss Re | 132.30 |